Patent · US Active

Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis

US8021644B2 · kind B2 · utility

15Cited by
63References
4Claims
0Family size

Assignee

Inventor

Key dates

Filing dateAug 3, 2007
Grant dateSep 20, 2011
Priority date
Expiry dateJun 30, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to biochemical methods for determining reverse cholesterol transport. Specifically, the rates of the two arms of reverse cholesterol transport (HDL or first arm and post-HDL or second arm) are obtained by measuring the flow of unlabeled cholesterol from tissues into plasma HDL and from plasma HDL to bile acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.